Pay in 4 interest-free payments of $7.42 Learn more
Ships within 48 hours · Estimated delivery Nov 4 - Nov 9
10.1007/s12272-013-0051-4 92 ShinjyoN.KitaK
In another 2025 study, GLP-1 drugs were found to be beneficial in lowering the risk of heart disease and stroke in people with type 2 diabetes
Combination therapy and hybrid molecules that act through multiple receptors appear to maximize the beneficial outcomes, without increasing side effects of the single molecules
Researchers studying peptide signaling pathways and metabolic receptor interactions require high-quality compounds to maintain experimental accuracy
Mert I, Cetinkaya A, Gurler M, Turel CA, Celik H, Torun IE, Turel I (2022) Anti-inflammatory potential of liraglutide, a glucagon-like peptide-1 receptor agonist, in rats with peripheral acute inflammation
US$ 20.22
US$ 24.99
US$ 21.20
US$ 27.19
US$ 27.37
US$ 27.26
